TRANCE/RANKL Knockout Mice Are Protected from Bone Erosion in a Serum Transfer Model of Arthritis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Leisen, 1988, The erosive front: a topographic study of the junction between the pannus and the subchondral plate in the macerated rheumatoid metacarpal head, J Rheumatol, 15, 17
Bromley, 1984, Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint, Arthritis Rheum, 27, 968, 10.1002/art.1780270902
Gravallese, 2000, Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor, Arthritis Rheum, 43, 250, 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P
Hummel, 1998, Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction, J Rheumatol, 25, 1887
Hattersley, 1989, Generation of osteoclastic function in mouse bone marrow cultures: multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for osteoclastic differentiation, Endocrinology, 124, 1689, 10.1210/endo-124-4-1689
Kurihara, 1990, Sequential expression of phenotype markers for osteoclasts during differentiation of precursors for multinucleated cells formed in long term human marrow cultures, Endocrinology, 127, 3215, 10.1210/endo-127-6-3215
Faust, 1999, Osteoclast markers accumulate on cells developing from human peripheral blood mononuclear precursors, J Cell Biochem, 72, 67, 10.1002/(SICI)1097-4644(19990101)72:1<67::AID-JCB8>3.0.CO;2-A
Suda, 1992, Modulation of osteoclast differentiation, Endocr Rev, 13, 66
Gravallese, 1998, Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis, Am J Pathol, 152, 943
Hattersley, 1989, Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures, Endocrinology, 125, 1606, 10.1210/endo-125-3-1606
Lee, 1995, Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin, Endocrinology, 136, 4572, 10.1210/endo.136.10.7664679
Suzuki, 1998, Osteoclast-like cells in murine collagen induced arthritis, J Rheumatol, 25, 1154
Kuratani, 1998, Induction of abundant osteoclast-like multinucleated giant cells in adjuvant arthritic rats with accompanying disordered high bone turnover, Histol Histopathology, 13, 751
Romas, 2000, Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis, Arthritis Rheum, 43, 821, 10.1002/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T
Lacey, 1998, Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation, Cell, 93, 165, 10.1016/S0092-8674(00)81569-X
Yasuda, 1998, Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL, Proc Natl Acad Sci USA, 95, 3597, 10.1073/pnas.95.7.3597
Wong, 1997, TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor, J Exp Med, 186, 2075, 10.1084/jem.186.12.2075
Anderson, 1997, A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function, Nature, 390, 175, 10.1038/36593
Hofbauer, 2000, The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption, J Bone Miner Res, 15, 2, 10.1359/jbmr.2000.15.1.2
Hofbauer, 1998, Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines, Biochem Biophys Res Commun, 250, 776, 10.1006/bbrc.1998.9394
Horwood, 1998, Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells, Endocrinology, 139, 4743, 10.1210/endo.139.11.6433
Yasuda, 1999, A novel molecular mechanism modulating osteoclast differentiation and function, Bone, 25, 109, 10.1016/S8756-3282(99)00121-0
Simonet, 1997, Osteoprotegerin: a novel secreted protein involved in the regulation of bone density, Cell, 89, 309, 10.1016/S0092-8674(00)80209-3
Yasuda, 1998, Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro, Endocrinology, 139, 1329, 10.1210/endo.139.3.5837
Kong, 1999, OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis, Nature, 397, 315, 10.1038/16852
Kim, 2000, Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene, Proc Natl Acad Sci USA, 97, 10905, 10.1073/pnas.200294797
Kim, 2000, Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE, J Exp Med, 192, 1467, 10.1084/jem.192.10.1467
Josien, 2000, TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo, J Exp Med, 191, 495, 10.1084/jem.191.3.495
Takayanagi, 2000, Involvement of receptor activator of nuclear factor kappa-B ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis, Arthritis Rheum, 43, 259, 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W
Kong, 1999, Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand, Nature, 402, 304, 10.1038/46303
Horwood, 1999, Activated T lymphocytes support osteoclast formation in vitro, Biochem Biophys Res Commun, 265, 144, 10.1006/bbrc.1999.1623
Matsumoto, 1999, Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme, Science, 286, 1732, 10.1126/science.286.5445.1732
Korganow, 1999, From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins, Immunity, 10, 451, 10.1016/S1074-7613(00)80045-X
Kouskoff, 1996, Organ-specific disease provoked by systemic autoimmunity, Cell, 87, 811, 10.1016/S0092-8674(00)81989-3
Ruegsegger, 1996, A microtomographic system for the nondestructive evaluation of bone architecture, Calcif Tissue Int, 58, 24, 10.1007/BF02509542
Muller, 1998, Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography, Bone, 23, 59, 10.1016/S8756-3282(98)00068-4
Balto, 2000, Quantification of periapical bone destruction in mice by micro-computed tomography, J Dent Res, 79, 35, 10.1177/00220345000790010401
Muller, 1997, Micro-tomographic imaging for the nondestructive evaluation of trabecular bone architecture, Stud Health Technol Inform, 40, 61
Muller, 1994, Non-invasive bone biopsy: a new method to analyze and display the three-dimensional structure of trabecular bone, Phys Med Biol, 39, 145, 10.1088/0031-9155/39/1/009
Glowacki, 1991, A role for osteocalcin in osteoclast differentiation, J Cell Biochem, 45, 292, 10.1002/jcb.240450312
Bendele, 1999, Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data, Arthritis Rheum, 42, 498, 10.1002/1529-0131(199904)42:3<498::AID-ANR15>3.0.CO;2-A
Ji, 2001, Genetic influences on the end-stage effector phase of arthritis, J Exp Med, 194, 321, 10.1084/jem.194.3.321
Chambers, 1984, Failure of cells of the mononuclear phagocyte series to resorb bone, Calcif Tissue Int, 36, 556, 10.1007/BF02405365
Higuchi, 1999, Gene expression during osteoclast-like cell formation induced by antifusion regulatory protein-1/CD98/4F2 monoclonal antibodies (MAbs): c-src is selectively induced by anti-FRP-1 MAb, Bone, 25, 17, 10.1016/S8756-3282(99)00103-9
Holliday, 1997, Initiation of osteoclast bone resorption by interstitial collagenase, J Biol Chem, 272, 22053, 10.1074/jbc.272.35.22053
Kaneko, 2001, Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis, Rheumatology, 40, 247, 10.1093/rheumatology/40.3.247
Pap, 2000, Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis, Arthritis Res, 2, 361, 10.1186/ar113
Francis, 1989, NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis, Int J Tiss Reac, 11, 239
Eggelmeijer, 1996, Increased bone mass with pamidronate treatment in rheumatoid arthritis; results of a three-year randomized double-blind trial, Arthritis Rheum, 39, 396, 10.1002/art.1780390307